Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
24°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
Today 10:17 EST
Tickers
NEWS
NVS
Tags
NVS
News
Briefs
From
Benzinga
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
November 12, 2024
Tickers
ARKG
NEWS
NVS
SDGR
Tags
Benzinga
Market News
Health Care
From
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Tickers
ABBV
AMGN
BIIB
BMY
Tags
Benzinga
LLY
Market News
From
Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
October 30, 2024
Tickers
BMY
GILD
LYEL
NEWS
Tags
Downgrades
Stories That Matter
Analyst Color
From
Benzinga
Novartis Ag (NVS) Q3 2024 Earnings Call Transcript
October 29, 2024
Tickers
NVS
Tags
Recent Press Releases
NVS
Market News
From
Motley Fool
Novartis Q3 Earnings Beats Expectations On Strong Sales From Key Drugs, Lifts 2024 Outlook
October 29, 2024
Tickers
NEWS
NVS
Tags
Stories That Matter
Guidance
Top Stories
From
Benzinga
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
October 28, 2024
Tickers
GLUE
NEWS
NVS
Tags
GLUE
Benzinga
Market News
From
Benzinga
3 Absurdly Cheap Stocks That Pay High Dividends
October 24, 2024
Tickers
GILD
MRK
NVS
Tags
NVS
MRK
Market News
From
Motley Fool
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
October 18, 2024
Tickers
CTLT
NEWS
NVO
NVS
Tags
Biotech
SRPT
Large Cap
From
Benzinga
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
October 18, 2024
Tickers
NEWS
NVS
SNY
Tags
Market News
Benzinga
Large Cap
From
Benzinga
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
October 17, 2024
Tickers
NVS
Tags
Market News
NVS
Recent Press Releases
From
Motley Fool
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
October 16, 2024
Tickers
ALPMF
ALPMY
APLS
NEWS
Tags
Trading Ideas
Benzinga
Analyst Ratings
From
Benzinga
Looking Into Novartis's Recent Short Interest
October 14, 2024
Tickers
NVS
Tags
NVS
Market News
BZI/SHORTHIST
From
Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
October 14, 2024
Tickers
ABBV
NVS
Tags
Recent Press Releases
ABBV
Market News
From
Motley Fool
Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm
October 10, 2024
Tickers
NEWS
NVS
OKUR
Tags
Biotech
Health Care
Market News
From
Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
October 01, 2024
Tickers
AZN
LLY
NEWS
NVO
Tags
Government
General
Regulations
From
Benzinga
Incyte Downgraded - Analyst Notes Intense Competition, Particularly In Larger Markets
September 18, 2024
Tickers
INCY
NEWS
NVS
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
September 18, 2024
Tickers
NEWS
NVS
SNY
Tags
NVS
Briefs
SNY
From
Benzinga
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
September 11, 2024
Tickers
ACET
ANIP
NEWS
NVS
Tags
Analyst Ratings
SUPN
Market News
From
Benzinga
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
September 11, 2024
Tickers
APP
ASO
ATOS
CAC
Tags
KRYS
Price Target
NVS
From
Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
Tickers
AZN
BMY
ELVN
NEWS
Tags
RHHBY
General
why it's moving
From
Benzinga
Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts
September 05, 2024
Tickers
NEWS
NVO
NVS
Tags
Large Cap
Biotech
Equities
From
Benzinga
S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
September 05, 2024
Tickers
AI
CE
CHPT
CNM
Tags
EVTC
Markets
PT Changes
From
Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Tickers
AMGN
AZN
BMY
JNJ
Tags
BMY
Health Care
AI Generated
From
Benzinga
Novartis' Cholesterol-Lowering Drug Shows Encouraging Outcome In Late-Stage Study
August 28, 2024
Tickers
NEWS
NVS
Tags
Market News
Stories That Matter
Top Stories
From
Benzinga
Siemens Healthineers To Buy Novartis Diagnostics To Bolster Cancer Scan Business In $220M Deal
August 26, 2024
Tickers
NEWS
NVS
Tags
NVS
Briefs
News
From
Benzinga
2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200
August 18, 2024
Tickers
DXCM
NVS
Tags
NVS
DXCM
Market News
From
Motley Fool
Judge Rules Against Novartis' Effort To Halt Generic Launch Of Its Top-Selling Heart Disease Drug
August 13, 2024
Tickers
NEWS
NVS
Tags
Stories That Matter
Top Stories
General
From
Benzinga
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease
August 08, 2024
Tickers
NEWS
NVS
Tags
Benzinga
FDA
Market News
From
Benzinga
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
August 06, 2024
Tickers
NEWS
NVS
RARE
TMO
Tags
VTRS
Legal
General
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.